Arrowhead Pharmaceuticals, Inc.
ARWRNASDAQHealthcare● Active
$73.27
+$0.18(+0.24%)
Market Cap$10.3B
P/E Ratio—
52W High$82.26
52W Low$14.3
Arrowhead Pharmaceuticals, Inc.（ARWR）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ARWR · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.83B | $0.00B | $0.24B | $0.24B | $0.14B |
| Cost of Revenue | $0.00B | $0.02B | $0.01B | $0.01B | $0.00B |
| Gross Profit | $0.83B | ($0.02B) | $0.23B | $0.23B | $0.00B |
| Gross Margin %(computed) | 100.00% | -423.66% | 94.81% | 95.72% | 0.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.61B | $0.49B | $0.34B | $0.29B | $0.20B |
| G&A Expenses | $0.12B | $0.10B | $0.09B | $0.12B | $0.08B |
| Total Operating Expenses | $0.73B | $0.59B | $0.43B | $0.41B | $0.28B |
| Operating Income | $0.10B | ($0.60B) | ($0.21B) | ($0.18B) | ($0.15B) |
| Operating Margin %(computed) | 11.86% | — | -85.16% | -73.39% | -107.77% |
| Interest Income | $0.04B | $0.02B | $0.02B | $0.01B | $0.01B |
| Interest Expense | $0.09B | $0.03B | $0.02B | $0.00B | $0.00B |
| Income Before Tax | $0.05B | ($0.61B) | ($0.21B) | ($0.17B) | ($0.14B) |
| Income Tax Expense | $0.02B | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | ($0.60B) | ($0.21B) | ($0.18B) | ($0.14B) |
| Net Margin %(computed) | -0.20% | — | -85.27% | -72.39% | -101.85% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-5.00 | $-1.91 | $-1.67 | $-1.36 |
| Wtd Avg Shares | 0.13B | 0.12B | 0.11B | 0.11B | 0.10B |
| EBITDA | $0.16B | ($0.56B) | ($0.18B) | ($0.16B) | ($0.13B) |
| EBITDA Margin %(computed) | 19.87% | — | -72.97% | -66.72% | -95.87% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Arrowhead Pharmaceuticals, Inc.
关于Arrowhead Pharmaceuticals, Inc.（ARWR）损益表
Arrowhead Pharmaceuticals, Inc.（ARWR）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ARWR实现营收$0.83B，毛利润$0.83B（毛利率100.00%），净利润($0.00B)（净利率-0.20%）。
常见问题
ARWR · 4 问Arrowhead Pharmaceuticals, Inc.（ARWR）2025财年营收为$0.83B，同比up23258.2%。
ARWR revenueARWR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08